Stock-based compensation (Tables)
|
3 Months Ended |
Jun. 30, 2026 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of stock-based compensation expense |
Stock-based compensation expense was classified in the consolidated statements of operations as follows: | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | | | 2026 | | 2025 | | | | | | Research and development | $ | 3,615 | | | $ | 4,689 | | | | | | | Selling, general and administrative | 4,059 | | | 4,073 | | | | | | | $ | 7,674 | | | $ | 8,762 | | | | | |
The following table summarizes stock-based compensation expense by award type for the three months ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | | | 2026 | | 2025 | | | | | | Stock options | $ | 3,460 | | | $ | 4,137 | | | | | | Restricted and performance stock units | 4,214 | | | 4,625 | | | | | | | $ | 7,674 | | | $ | 8,762 | | | | | |
|
| Schedule of assumptions used to determine the grant-date fair value of stock options granted |
The following table presents, on a weighted-average basis, the assumptions that the Company used to determine the grant-date fair value of stock options granted to employees and directors: | | | | | | | | | | | | | | | | Three Months Ended June 30, | | | 2026 | | 2025 | | | | | Risk-free interest rate | 4.06 | % | | 3.97 | % | | | | | Expected term (in years) | 6.0 | | 6.0 | | | | | Expected volatility | 106.7 | % | | 76.3 | % | | | | | Expected dividend yield | 0 | % | | 0 | % | | | |
|
| Schedule of of stock option activity |
The following table summarizes the Company’s stock option activity: | | | | | | | | | | | | | | | | | | | | | | | | | Number of Shares | | Weighted Average Exercise Price | | Weighted Average Contractual Term (Years) | | Aggregate Intrinsic Value | | Outstanding as of March 31, 2026 | 11,785,458 | | | $ | 14.12 | | | 5.63 | | $ | 4,323 | | | Granted | 2,167,083 | | | 7.63 | | | | | | | Exercised | (118,075) | | | 8.49 | | | | | | | Cancelled | (1,341,594) | | | 14.53 | | | | | | | Outstanding as of June 30, 2026 | 12,492,872 | | | 13.00 | | | 5.71 | | 25,470 | | | Options exercisable as of June 30, 2026 | 8,594,036 | | | 14.99 | | | 4.23 | | 14,195 | | | Options vested and expected to vest as of June 30, 2026 | 12,492,872 | | | $ | 13.00 | | | 5.71 | | $ | 25,470 | |
|
| Schedule of share-based payment arrangement, restricted stock and restricted stock unit, activity |
A summary of the changes in the Company’s RSUs and PSUs during the three months ended June 30, 2026 is as follows: | | | | | | | | | | | | | Number of Restricted Shares | | Weighted Average Grant Date Fair Value | | Outstanding as of March 31, 2026 | 5,508,882 | | | $ | 9.69 | | | Granted | 2,510,630 | | | 7.65 | | | Vested | (1,144,368) | | | 10.47 | | | Cancelled | (2,049,553) | | | 8.79 | | | Outstanding as of June 30, 2026 | 4,825,591 | | | $ | 8.82 | |
|